Matthew R Sydes

Процитировано

	Все	Начиная с 2020 г.
Статистика цитирования	40166	20147
h-индекс	85	61
i10-индекс	219	178

4100

2050

1025

3075

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025112 127 197 257 307 357 474 545 676 734 907 1023 1229 1590 2054 2439 2812 3244 3714 4057 4061 3755 3940 575

Общий доступ

Просмотреть все

232 статьи

5 статей*

доступно

недоступно

На основе финансирования

Соавторы

Nicholas JamesProfessor of Prostate and Bladder Cancer Research, Institute of Cancer ResearchПодтвержден адрес электронной почты в домене icr.ac.uk
Wendy R. ParulekarCanadian Cancer Trials Group, Queen's UniversityПодтвержден адрес электронной почты в домене ctg.queensu.ca
Gerhardt AttardUniversity College London Cancer InstituteПодтвержден адрес электронной почты в домене ucl.ac.uk
Christopher SweeneyUniversity of AdelaideПодтвержден адрес электронной почты в домене adelaide.edu.au
Johann de BonoInstitute of Cancer ResearchПодтвержден адрес электронной почты в домене icr.ac.uk
Pancras CW HogendoornProfessor of Pathology, Leiden University Medical CenterПодтвержден адрес электронной почты в домене lumc.nl
Bertrand TOMBALCliniques universitaires Saint LucПодтвержден адрес электронной почты в домене uclouvain.be
Emma HallProfessor of Oncology Clinical Trials, The Institute of Cancer ResearchПодтвержден адрес электронной почты в домене icr.ac.uk
Silke GillessenProf. Dr. Med. Silke GillessenHead Medical Oncology Dept. / Medical and Scientific Director, Oncology Institute of Southern Switzerland (IOSI)Подтвержден адрес электронной почты в домене eoc.ch
Hans GelderblomLUMCПодтвержден адрес электронной почты в домене lumc.nl
Carrol GambleProfessor of Medical Statistics, University of LiverpoolПодтвержден адрес электронной почты в домене liverpool.ac.uk
Catharine WestEmerita Professor of Radiation Biology, The University of ManchesterПодтвержден адрес электронной почты в домене manchester.ac.uk
Johnson PWProfessor of Medical Oncology, University of SouthamptonПодтвержден адрес электронной почты в домене soton.ac.uk
Robert HuddartInstitution of Cancer ResearchПодтвержден адрес электронной почты в домене icr.ac.uk
Alison M DunningCentre for Cancer Genetic Epidemiology, Dept of Oncology, University of CambridgeПодтвержден адрес электронной почты в домене medschl.cam.ac.uk
Howard KynastonProfessor of Urological SurgeryПодтвержден адрес электронной почты в домене cf.ac.uk
David MathesonUniversity of WolverhamptonПодтвержден адрес электронной почты в домене wlv.ac.uk
John RadfordProfessor of Medical Oncology, University of ManchesterПодтвержден адрес электронной почты в домене manchester.ac.uk
David J FisherStatistician, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and MethodologyПодтвержден адрес электронной почты в домене ucl.ac.uk
Harry Schoutenemeritus hoogleraar hematologieПодтвержден адрес электронной почты в домене mumc.nl

Matthew R Sydes

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College

Подтвержден адрес электронной почты в домене ucl.ac.uk - Главная страница

Clinical trial conduct multi-arm multi-stage trials and platform protocols routinely-collected electronic health records acad


Название По числу цитат По году По названию	Процитировано Процитировано	Год
Practical methods for incorporating summary time-to-event data into meta-analysis JF Tierney, LA Stewart, D Ghersi, S Burdett, MR Sydes Trials 8, 1-16, 2007	5603	2007
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage … ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ... The Lancet 387 (10024), 1163-1177, 2016	2231	2016
Abiraterone for prostate cancer not previously treated with hormone therapy ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ... New England Journal of Medicine 377 (4), 338-351, 2017	1915	2017
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study GC Barnett, CE Coles, RM Elliott, C Baynes, C Luccarini, D Conroy, ... The lancet oncology 13 (1), 65-77, 2012	1840	2012
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial A Cuschieri, S Weeden, J Fielding, J Bancewicz, J Craven, V Joypaul, ... British journal of cancer 79 (9), 1522-1530, 1999	1839	1999
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial CC Parker, ND James, CD Brawley, NW Clarke, AP Hoyle, A Ali, ... The Lancet 392 (10162), 2353-2366, 2018	1206	2018
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial DP Dearnaley, MR Sydes, JD Graham, EG Aird, D Bottomley, RA Cowan, ... The lancet oncology 8 (6), 475-487, 2007	1100	2007
Adaptive designs in clinical trials: why use them, and how to run and report them P Pallmann, AW Bedding, B Choodari-Oskooei, M Dimairo, L Flight, ... BMC medicine 16, 1-15, 2018	713	2018
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial P Warde, M Mason, K Ding, P Kirkbride, M Brundage, R Cowan, ... The Lancet 378 (9809), 2104-2111, 2011	706	2011
High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomized European CUP trial HC Schouten, W Qian, S Kvaloy, A Porcellini, H Hagberg, HE Johnsen, ... Journal of clinical oncology 21 (21), 3918-3927, 2003	645	2003
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort S Smeland, SS Bielack, J Whelan, M Bernstein, P Hogendoorn, MD Krailo, ... European journal of cancer 109, 36-50, 2019	591	2019
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial DP Dearnaley, G Jovic, I Syndikus, V Khoo, RA Cowan, JD Graham, ... The lancet oncology 15 (4), 464-473, 2014	553	2014
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label … NM Marina, S Smeland, SS Bielack, M Bernstein, G Jovic, MD Krailo, ... The Lancet Oncology 17 (10), 1396-1408, 2016	552	2016
Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019) ND James, MR Spears, NW Clarke, DP Dearnaley, JS De Bono, J Gale, ... European urology 67 (6), 1028-1038, 2015	543	2015
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018	539	2018
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of … CL Vale, S Burdett, LHM Rydzewska, L Albiges, NW Clarke, D Fisher, ... The lancet oncology 17 (2), 243-256, 2016	506	2016
Perioperative β-blockade (Pobble) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial JT Powell, POBBLE Trial Investigators Journal of Vascular Surgery 41 (4), 602-609, 2005	461	2005
Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma … IJ Lewis, MA Nooij, J Whelan, MR Sydes, R Grimer, PCW Hogendoorn, ... Journal of the National Cancer Institute 99 (2), 112-128, 2007	453	2007
Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ... Journal of Clinical Oncology 35 (27), 3097-3104, 2017	437	2017
Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with … RJ Sylvester, W Oosterlinck, S Holmang, MR Sydes, A Birtle, ... European urology 69 (2), 231-244, 2016	435	2016

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы